Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma

NCT00030849 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: recombinant interferon alfa
DRUG: bexarotene

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]